Wegovy FlexTouch Pen UK - Genuine Novo Nordisk £69.00

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy FlexTouch UK Price - From £69.00

Get genuine Wegovy FlexTouch at the cheapest UK price from £69.00 — Save £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £69.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Wegovy FlexTouch Pen UK: Genuine Novo Nordisk Semaglutide Injections

The Wegovy FlexTouch pen UK is the only licensed semaglutide injection device manufactured by Novo Nordisk for chronic weight management in adults with obesity or overweight with weight-related conditions. As a UK-registered pharmacy (GPhC 9012511), Cured Pharmacy supplies 100% genuine Wegovy FlexTouch pens with full MHRA approval, ensuring every device you receive is authentic, refrigerated correctly, and dispensed following clinical assessment by our UK prescribing team. Unlike generic alternatives or unlicensed compounded versions, the Wegovy FlexTouch pen UK delivers precise, pre-measured semaglutide doses through an easy-to-use injection system designed specifically for subcutaneous administration.

What Makes the Wegovy FlexTouch Pen UK Different?

The Wegovy FlexTouch pen UK is Novo Nordisk's proprietary injection device, engineered exclusively for semaglutide 2.4mg weekly dosing in weight management. Unlike multi-dose vials requiring manual drawing, the FlexTouch system uses a pre-filled, single-patient pen with an integrated dose selector and hidden needle mechanism[1]. Each pen contains four weekly doses, colour-coded by strength to prevent dosing errors during the escalation schedule.

Clinical trials demonstrate that the FlexTouch pen design significantly improves patient adherence compared to traditional syringes, with 89% of participants in the STEP programme reporting the device as 'easy' or 'very easy' to use[2]. The pen's dose confirmation window provides visual verification of complete injection, whilst the audible click mechanism ensures accurate dose delivery. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) emphasises that genuine Wegovy FlexTouch pens UK undergo rigorous quality controls throughout the cold chain, from Novo Nordisk's Danish manufacturing facility to our GPhC-registered dispensary.

Wegovy FlexTouch Pen UK Dosing Schedule and Pen Strengths

The Wegovy FlexTouch pen UK follows a mandatory five-month dose escalation protocol designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes. Each dosing phase requires a specific pen strength, and patients cannot skip steps or accelerate the schedule without prescriber approval[3].

Month 1 uses the 0.25mg FlexTouch pen (four weekly injections), followed by Month 2 at 0.5mg, Month 3 at 1mg, Month 4 at 1.7mg, and Month 5 onwards at the maintenance dose of 2.4mg weekly. Each Wegovy FlexTouch pen UK contains exactly four doses of the specified strength, with the pen discarded after the fourth injection even if residual medication appears to remain. The STEP 1 trial showed that patients who completed the full escalation schedule achieved an average 14.9% body weight reduction at 68 weeks, compared to 2.4% with placebo[1].

Understanding FlexTouch Pen Colour Coding

Novo Nordisk colour-codes each Wegovy FlexTouch pen UK strength to prevent administration errors: 0.25mg pens feature a grey label, 0.5mg are light blue, 1mg are pink, 1.7mg are yellow, and the 2.4mg maintenance pens are dark blue. This visual system is particularly important for patients managing multiple medication schedules, as selecting the wrong pen strength could lead to underdosing (reduced efficacy) or overdosing (increased side effect risk). Always verify the dose window matches your prescription before injecting.

How to Use Your Wegovy FlexTouch Pen UK Correctly

Proper administration technique maximises the effectiveness of your Wegovy FlexTouch pen UK whilst minimising injection site reactions. Before each injection, remove the pen from refrigeration and allow it to reach room temperature for approximately 30 minutes—injecting cold medication increases discomfort and may affect absorption. Attach a new NovoFine or NovoTwist needle (sold separately or included with your prescription), prime the pen by dialling to the flow check symbol, and inject into the abdomen, thigh, or upper arm subcutaneous tissue[4].

The FlexTouch pen UK mechanism requires holding the dose button down until the dose counter returns to zero, then counting slowly to six before withdrawing the needle. This ensures complete dose delivery, as premature removal can result in partial dosing. Rotate injection sites weekly to prevent lipohypertrophy (fatty lumps under the skin that impair absorption). Clinical data shows that consistent injection timing—choosing the same day each week—improves adherence and stabilises semaglutide blood levels[2].

Storage Requirements for FlexTouch Pens

Unopened Wegovy FlexTouch pens UK must be stored in a refrigerator at 2-8°C until first use, protected from light and never frozen. Once in use, the pen may be stored at room temperature (below 30°C) or continued refrigeration for up to 28 days with the pen cap on. After 28 days, discard the pen even if doses remain. During UK summer months, avoid leaving pens in hot cars or direct sunlight, as heat degrades semaglutide and renders the medication ineffective. Cured Pharmacy ships all Wegovy FlexTouch pens UK in validated cold chain packaging with temperature monitoring to ensure product integrity on arrival.

Treatment Active Ingredient Injection Frequency Starting Price
Wegovy FlexTouch Semaglutide 2.4mg Once weekly From £89.00
Mounjaro KwikPen Tirzepatide Once weekly From £145.00
Saxenda Liraglutide 3mg Once daily From £68.00
Wegovy Oral Tablet Semaglutide (oral) Once daily From £83.00

Wegovy FlexTouch Pen UK Pricing and Availability at Cured Pharmacy

Cured Pharmacy offers genuine Novo Nordisk Wegovy FlexTouch pens UK at competitive pricing, with transparent costs displayed before you complete your clinical consultation. Unlike high street pharmacies that require in-person appointments and may have inconsistent stock, our online service provides same-day prescription approval (subject to clinical suitability) and next-day delivery across the UK.

New patients receive £20 off their first order using code Weightlossnew, reducing the initial month's cost. Each Wegovy FlexTouch pen UK supplied by Cured Pharmacy includes the manufacturer's patient information leaflet, disposal guidance for used pens (sharps waste), and access to our pharmacist support line for injection technique queries. All prescriptions require completion of a three-minute online consultation reviewed by our UK-registered prescribers, ensuring semaglutide is clinically appropriate for your weight management goals.

Clinical Evidence Supporting Wegovy FlexTouch Pen UK Efficacy

The Wegovy FlexTouch pen UK delivers semaglutide at the 2.4mg maintenance dose validated across the STEP clinical trial programme, which enrolled over 4,500 adults with obesity or overweight with comorbidities. STEP 1 demonstrated that 83.5% of participants achieved at least 5% weight loss at 68 weeks, with 66.1% reaching 10% reduction and 48.0% achieving 15% or greater weight loss[1]. These outcomes significantly exceeded placebo and established semaglutide as the most effective pharmacological weight management intervention currently licensed in the UK.

STEP 5, a two-year extension study, showed sustained weight reduction of 15.2% from baseline with continued Wegovy FlexTouch pen UK use, alongside improvements in cardiovascular risk markers including blood pressure, lipid profiles, and glycaemic control[3]. The MHRA licensed Wegovy in 2023 following comprehensive review of this evidence, and NICE now recommends semaglutide 2.4mg as a specialist-initiated treatment option within NHS weight management services for eligible patients[4].

Real-World Effectiveness Data

Post-marketing surveillance of Wegovy FlexTouch pen UK users confirms that clinical trial results translate to routine practice, with UK registry data showing average 12-month weight loss of 12.3% among patients who maintained treatment adherence. Discontinuation rates due to side effects remain consistent with trial data at approximately 7%, predominantly gastrointestinal symptoms during dose escalation. Patients who complete the full five-month titration schedule show significantly better long-term adherence compared to those who attempt faster escalation, reinforcing the importance of following the prescribed Wegovy FlexTouch pen UK dosing protocol.

Common Questions About Wegovy FlexTouch Pen UK from Our Patients

As a UK-registered pharmacy dispensing Wegovy FlexTouch pens daily, our clinical team frequently addresses specific patient concerns about this treatment. The most common query relates to distinguishing genuine Novo Nordisk products from counterfeit or compounded alternatives circulating online—authentic Wegovy FlexTouch pens UK feature holographic labels, batch-traceable serial numbers, and arrive in sealed cartons with temperature indicators.

Patients also ask whether the FlexTouch pen UK can be reused or refilled. The device is single-patient use only and cannot be refilled; attempting to do so risks contamination and dosing errors. Each pen contains exactly four doses and must be discarded after 28 days or four injections, whichever comes first. Regarding needle compatibility, Wegovy FlexTouch pens UK work with all Novo Nordisk NovoFine or NovoTwist needles (4mm to 8mm lengths), with 4mm or 6mm needles recommended for most patients to ensure subcutaneous rather than intramuscular delivery[2]. Our superintendent pharmacist Tarun Kumar advises patients to inspect each new pen for clarity—semaglutide solution should be clear and colourless; any cloudiness, particles, or discolouration indicates the pen should not be used and must be returned for replacement.

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
  3. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., ... & Wharton, S. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 15 August 2026]
  4. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. [accessed 15 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Is the Wegovy FlexTouch pen UK available on the NHS?
Wegovy is licensed in the UK but NHS availability is limited to specialist weight management services in specific regions, with most patients accessing treatment privately. Cured Pharmacy supplies genuine Wegovy FlexTouch pens UK following private prescription by our UK-registered clinical team.
How long does one Wegovy FlexTouch pen UK last?
Each Wegovy FlexTouch pen contains exactly four weekly doses, providing one month of treatment. After four injections or 28 days from first use, the pen must be discarded even if medication appears to remain.
Can I buy Wegovy FlexTouch pen UK without prescription?
No—Wegovy is a prescription-only medicine (POM) in the UK and cannot legally be supplied without clinical assessment by a UK-registered prescriber. Cured Pharmacy provides a free online consultation reviewed by our prescribing team as part of every order.
What's the difference between Wegovy FlexTouch pen UK and Ozempic?
Both contain semaglutide manufactured by Novo Nordisk using FlexTouch pens, but Wegovy is licensed specifically for weight management at 2.4mg weekly, whilst Ozempic is licensed for type 2 diabetes at lower doses (0.5mg-1mg weekly). Using Ozempic off-label for weight loss is not recommended.
How do I know my Wegovy FlexTouch pen UK is genuine?
Authentic Novo Nordisk Wegovy FlexTouch pens feature holographic labels, batch-traceable serial numbers, and arrive in sealed cartons. Cured Pharmacy sources all stock directly from UK-licensed wholesalers with full cold chain documentation and MHRA compliance.
Can I travel abroad with my Wegovy FlexTouch pen UK?
Yes—carry Wegovy in hand luggage with your prescription or patient information leaflet as proof. Use a medical cooling case for flights over two hours, and research destination country regulations as some nations restrict semaglutide importation.
What happens if I miss a Wegovy FlexTouch pen UK dose?
If less than five days until your next scheduled dose, skip the missed dose and resume your regular weekly schedule. If more than five days remain, inject as soon as possible then continue weekly from that new day.
Does the Wegovy FlexTouch pen UK hurt to inject?
Most patients report minimal discomfort with the FlexTouch pen's hidden needle mechanism. Using shorter needles (4mm), allowing the pen to reach room temperature before injection, and rotating injection sites weekly all reduce injection site pain.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.